SHREE GANESH REMEDIES
Back to Balance Sheet
|
SHREE GANESH REMEDIES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹61 Cr | ₹52 Cr | ₹23 Cr | ₹19 Cr |
What is the latest Net Current Assets ratio of SHREE GANESH REMEDIES ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹61 Cr |
| Mar2024 | ₹52 Cr |
| Mar2020 | ₹23 Cr |
| Mar2019 | ₹19 Cr |
How is Net Current Assets of SHREE GANESH REMEDIES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹61 Cr | 19.16 | |
| Mar2024 | ₹52 Cr | 119.82 | |
| Mar2020 | ₹23 Cr | 23.20 | |
| Mar2019 | ₹19 Cr | - | |
Compare Net Current Assets of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹789.7 Cr | -5.4% | 16.3% | 5.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,938.0 Cr | -0.6% | -3.7% | 7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,361.0 Cr | 2.8% | 0.7% | -0.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,385.0 Cr | 2.4% | 2.1% | 40.8% | Stock Analytics | |
| CIPLA | ₹111,220.0 Cr | 0.1% | 2.2% | -5.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,899.0 Cr | 0.5% | -1.9% | 2.2% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | -5.4% |
16.3% |
5.7% |
| SENSEX | -1% |
-5% |
-9.2% |
You may also like the below Video Courses